Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA395136
Max Phase: Preclinical
Molecular Formula: C13H12Cl2F3N3O
Molecular Weight: 354.16
Molecule Type: Small molecule
Associated Items:
ID: ALA395136
Max Phase: Preclinical
Molecular Formula: C13H12Cl2F3N3O
Molecular Weight: 354.16
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCc1nnn(-c2c(Cl)cc(C(F)(F)F)cc2Cl)c1CO
Standard InChI: InChI=1S/C13H12Cl2F3N3O/c1-2-3-10-11(6-22)21(20-19-10)12-8(14)4-7(5-9(12)15)13(16,17)18/h4-5,22H,2-3,6H2,1H3
Standard InChI Key: RACLCHHASISYPU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 354.16 | Molecular Weight (Monoisotopic): 353.0310 | AlogP: 4.04 | #Rotatable Bonds: 4 |
Polar Surface Area: 50.94 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.19 | CX LogD: 4.19 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.90 | Np Likeness Score: -1.24 |
1. Alam MS, Huang J, Ozoe F, Matsumura F, Ozoe Y.. (2007) Synthesis, 3D-QSAR, and docking studies of 1-phenyl-1H-1,2,3-triazoles as selective antagonists for beta3 over alpha1beta2gamma2 GABA receptors., 15 (15): [PMID:17544280] [10.1016/j.bmc.2007.05.039] |
Source(1):